ISSUE HIGHLIGHTS
ISPOR Conferences
Featured Video: Voices From the Conference
ISPOR Conferences
Machine Learning: What’s on the Horizon for HEOR?
ISPOR Conferences
Are HTA Drug Reimbursement Decisions Taking Too Long?
ISPOR Conferences
Featured Video: Interview with Diane Munch, Pfizer, Inc
ISPOR Conferences
A Precise Approach to Precision Medicine in the Asia Pacific Region
ISPOR Conferences
Real-World Use of Biosimilar Medicines
ISPOR Conferences
Health Technology Assessment: Challenges and Lessons Learned in Asia
ISPOR Conferences
Striking the Right Note: Harmonization of HTA in the Asia Pacific Region
ISPOR Conferences
Understanding the Variation in EQ-5D-5L Values Across Asia
ISPOR Conferences
Third Version of the Korean Economic Evaluation Guidelines
ISPOR Conferences
Increased Access at Lower Cost: Multilevel Insurance Plans in China
ISPOR Conferences
Featured Video: Introductory Remarks From Nancy S. Berg
ISPOR Conferences
Use of Real-World Endpoints to Drive Next-Generation Healthcare
ISPOR Conferences
Stepping Past the QALY: What Is Next in Value Assessment Frameworks?
COLUMNS
ADDITIONAL RESOURCES
Latest News
Rethinking Value Assessment for Orphan Drugs
Dec 18, 2024
ISPOR Launches “HEOR Explained” Microsite
Dec 10, 2024
